Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-02-22 @ 2:53 AM
Study NCT ID:
NCT04405505
Status:
UNKNOWN
Last Update Posted:
2020-05-28
First Post:
2020-05-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC)
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-24
First Submit QC Date:
None
Study First Post Date:
2020-05-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-05-24
Last Update Post Date:
2020-05-28
Last Update Post Date Type:
ACTUAL